Therapy of Cervical Cancer Using 131i-Labeled Nanoparticles

Journal of International Medical Research - United Kingdom
doi 10.1177/0300060518761787
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Improving 131I Radioiodine Therapy by Hybrid Polymer-Grafted Gold Nanoparticles

International Journal of Nanomedicine
Organic ChemistryBiophysicsBiomaterialsPharmaceutical ScienceMedicineBioengineeringDrug DiscoveryNanoscienceNanotechnology
2019English

Rat Sodium Iodide Symporter Allows Using Lower Dose of 131I for Cancer Therapy

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2006English

Hypothyroidism and 131I Therapy

BMJ
1968English

Gold Nanoparticles Targeting Human Cervical Cancer Cells

Scholars International Journal of Obstetrics and Gynecology
2019English

Gold Nanoparticles in Cancer Therapy

Acta Pharmacologica Sinica
MedicinePharmacology
2011English

Pharmacodynamic Study of 131i-Labeled CA215 Antibody on an Animal Model of Estrogen-Resistant OC-3-VGH Ovarian Cancer

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2015English

Hybrid Nanoparticles for Combination Therapy of Cancer

Journal of Controlled Release
Pharmaceutical Science
2015English

SPECT Imaging of Neuropilin Receptor Type-1 Expression With 131i-Labeled Monoclonal Antibody

International Journal of Oncology
Cancer ResearchOncology
2016English

Nanoparticles for Effective Combination Therapy of Cancer

International Journal of Nanotechnology and Nanomedicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy